Actuate Therapeutics, Inc. (ACTU) Financial Statements

34 Followers

Actuate Therapeutics, Inc. Financial Overview

Actuate Therapeutics, Inc.'s market cap is currently $40.78M. The company's EPS TTM is $-1.406; its P/E ratio is -7.81; Actuate Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -22.50M	$ -25.16M	$ -24.97M	$ -20.21M
EBITDA	$ -22.50M	$ -25.16M	$ -24.43M	$ -20.08M
Net Income	$ -22.23M	$ -27.29M	$ -24.74M	$ -20.16M
Balance Sheet
Cash & Short-Term Investments	$ 13.16M	$ 8.64M	$ 2.96M	$ 20.45M
Total Assets	$ 14.04M	$ 9.32M	$ 3.00M	$ 20.48M
Total Debt	$ 404.99K	$ 0.00	$ 0.00	$ 404.99K
Net Debt	$ -12.75M	$ -8.64M	$ -2.96M	$ -20.04M
Total Liabilities	$ 6.11M	$ 9.21M	$ 102.62M	$ 5.65M
Stockholders' Equity	$ 7.92M	$ 104.19K	$ -99.63M	$ 14.83M
Cash Flow
Free Cash Flow	$ -19.21M	$ -21.84M	$ -21.63M	$ -17.79M
Operating Cash Flow	$ -19.21M	$ -21.84M	$ -21.63M	$ -17.79M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 23.72M	$ 27.53M	$ 4.13M	$ 19.26M

Currency in USD

Actuate Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Actuate Therapeutics, Inc. Debt to Assets

Balance Sheet >

Actuate Therapeutics, Inc. Cash Flow

Cash Flow >

Actuate Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >